Amyotrophic Lateral Sclerosis: all 1,000 studies
Page 3 of 10. Open to participants first (284), then studies with results posted, then the rest; newest registration first within each.
- Development of Targeted RNA-Seq for Amyotrophic Lateral Sclerosis DiagnosisRecruitingNCT06083584
- The Living With a Long-Term Condition StudyRecruitingNCT06072287
- Effects of Probiotics in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia Spectrum Disorder (ALS-FTDSD) PatientsRecruitingNCT06051123Not applicable
- Remote Home Assessment of Patients With Amyotrophic Lateral SclerosisRecruitingNCT06046599
- Alleviating Persistent Dyspnea in Amyotrophic Lateral Sclerosis Patients Treated With Non-Invasive Ventilation Through Immersive Virtual RealityRecruitingNCT06021938Not applicable
- A Phase 1, SAD and MAD Study to Evaluate the Safety and Tolerability of FB418RecruitingNCT05995782Phase 1
- Quantitative and Repetitive TMS in ALS - Recruiting for Stage 2RecruitingNCT05983211Not applicable
- ALS/MND Natural History Study Data RepositoryRecruitingNCT05966038
- A Double-blind Randomised, Placebo-controlled Clinical Trial to Test Ambroxol Treatment in ALSRecruitingNCT05959850Phase 2
- Telehealth Implementation of Brain-Computer InterfaceRecruitingNCT05951556Not applicable
- MindEx: A Novel, Multifocal, Cognitive Brain-Machine Interface SystemRecruitingNCT05936619Not applicable
- Clinical Study to Evaluate the Efficacy and Safety of FB1006 in the Treatment of ALS PatientsRecruitingNCT05923905Phase 4
- Amyotrophic Lateral Sclerosis RegistryNot yet recruitingNCT05892822
- Investigation of Cannabinoid 2-receptor Expression in the Brain and Spine of ALS-patients Compared to Healthy Controls With PET (18F-RoSMALS)Not yet recruitingNCT05880563Phase 1
- Effect of Salbutamol on Walking Capacity in Ambulatory ALS PatientsNot yet recruitingNCT05860244Phase 2
- Breathing With Amyotrophic Lateral SclerosisRecruitingNCT05819931Not applicable
- Technical Evaluation of Earswitch Phase ANot yet recruitingNCT05784727Not applicable
- ALS Spinal Cord Gray and White Matter StudyRecruitingNCT05764434
- Longitudinal Assessment of Autonomic and Sensory Nervous System in ALSRecruitingNCT05747937Not applicable
- Effects of Long Term Ventilation Support on the Quality of Life of ALS Patients and Their FamiliesRecruitingNCT05744310Not applicable
- Rehabilitation in SOD1 ALS Treated With TofersenEnrolling by invitationNCT05725759
- Feasibility of the BrainGate2 Neural Interface System in Persons With TetraplegiaRecruitingNCT05724173Not applicable
- Impairments of Neuro-muscular Communication in Motor-Neuron Disease: A Bio-Marker for Early and Personalised DiagnosisRecruitingNCT05663008
- Anticipated Patient and Caregiver BurdenRecruitingNCT05632757Not applicable
- Studies in Amyotrophic Lateral Sclerosis (ALS) and Other Neurodegenerative Motor Neuron DisordersRecruitingNCT05474235
- iBCI Optimization for Veterans With ParalysisNot yet recruitingNCT05470478Not applicable
- Clinical Trial - Analyzing Participation Experiences Of Amyotrophic Lateral Sclerosis PatientsNot yet recruitingNCT05423678
- Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy VolunteersRecruitingNCT05395624Phase 1/2
- Control Cohort CTRL COHRecruitingNCT05370079Not applicable
- Stratification of Presymptomatic Amyotrophic Lateral Sclerosis: the Development of Novel Imaging BiomarkersRecruitingNCT05358431Not applicable
- Contribution of Diaphragmatic Ultrasound for Monitoring Diaphragmatic Function in Patients With Amyotrophic Lateral SclerosisRecruitingNCT05352958
- mGluR5 Imaging in ALS Using PETRecruitingNCT05340660Not applicable
- Dysphagia, QoL and Attitudes Towards PEG in ALS PatientsRecruitingNCT05336760
- Volume Mode Non-invasive Ventilation in Amyotrophic Lateral SclerosisRecruitingNCT05328492Not applicable
- A Longitudinal Analysis of Biomarkers in Patients With ALSRecruitingNCT05309408
- Three Intermediate Expanded Access Protocols (EAP) CNMAu8.EAP01, CNMAu8.EAP02, and CNMAu8.EAP06 for ALSAvailableNCT05281484
- Comprehensive Analysis Platform To Understand, Remedy and Eliminate ALSRecruitingNCT05204017
- Use of 1 Minute Sit to Stand Test for Physical Capacity and Effort Related Desaturation in Amyotrophic Lateral SclerosisNot yet recruitingNCT05151211
- Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home MeasuresRecruitingNCT05137665
- Polysomnographic Titration of Non-invasive Ventilation in Motor Neurone DiseaseRecruitingNCT05136222Not applicable
- Genetic Study of Amyotrophic Lateral Sclerosis in NorwayRecruitingNCT05119387
- Biospecimen Biorepository for the Study of ALS, ALS-FTD and Similar Neurodegenerative DisordersRecruitingNCT05116943
- Cell Signaling, Reinnervation and Metabolism in Kennedy Disease and Amyotrophic Lateral Sclerosis (ALS)RecruitingNCT05107349Not applicable
- Telespirometry in Amyotrophic Lateral Sclerosis (ALS)Enrolling by invitationNCT05106569
- Tideglusib for the Treatment of Amyotrophic Lateral SclerosisNot yet recruitingNCT05105958Phase 2
- Intermuscular Coherence as a Biomarker for ALSRecruitingNCT05104710
- Analysis of Human ALS Tissues and Registry of ALS PatientsRecruitingNCT05067179
- Explore Biomarkers of Motor Neuron Disease/Frontal Dementia Spectrum Disease in ChinaEnrolling by invitationNCT04961450
- China Amyotrophic Lateral Sclerosis Registry of Patients With Traditional Chinese MedicineRecruitingNCT04885374
- Continuous Measurement of Activity in Patients With Muscle Pathology and in Control Subjects. ActiSLA Part.RecruitingNCT04882904Not applicable
- Magnetic Imaging for Diagnostic of Amyotrophic Lateral SclerosisRecruitingNCT04868994Not applicable
- Expression Profile Study of Macrophages From Patients Affected by ALS or Other Related Motor ImpairmentsRecruitingNCT04816227
- UPenn Observational Research Repository on Neurodegenerative DiseaseRecruitingNCT04715399
- Systematic Assessment of Laryngopharyngeal Function in Patients With Neurodegenerative DiseasesRecruitingNCT04706234
- A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of TBNNot yet recruitingNCT04667013Phase 1
- Natural History and Clinical Features of Amyotrophic Lateral Sclerosis (ALS)RecruitingNCT04454892
- ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)RecruitingNCT04363684
- Motor Neurone Disease - Systematic Multi-Arm Adaptive Randomised TrialRecruitingNCT04302870Phase 2/3
- RAPA-501 Therapy for ALSRecruitingNCT04220190Phase 2/3
- Biomarkers in Different Types of Amyotrophic Lateral Sclerosis (ALS) Patients Being Treated With EdaravoneRecruitingNCT04097158
- Validation of the "ExSpiron©" in Patients With ALSNot yet recruitingNCT04089696Not applicable
- A Registered Cohort Study on Amyotrophic Lateral SclerosisRecruitingNCT04008329
- Outcomes Mandate National Integration With Cannabis as MedicineRecruitingNCT03944447Phase 2
- Randomized, Double-blind, Safety and Efficacy of Recombinant Human Erythropoietin in Amyotrophic Lateral SclerosisRecruitingNCT03835507Phase 1/2
- Awareness Detection and Communication in Disorders of ConsciousnessRecruitingNCT03827187Not applicable
- Investigation on the Cortical Communication (CortiCom) SystemRecruitingNCT03567213Not applicable
- Clinical Procedures to Support Research in ALSRecruitingNCT03489278
- Investigation of the Epidemiological Factors Associated With the Development of Amyotrophic Lateral Sclerosis (ALS)RecruitingNCT03366506
- Retinal Imaging in Neurodegenerative DiseaseRecruitingNCT03233646
- Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal DementiaRecruitingNCT03225144
- Biomarkers of Synaptic Damage in Multiple SclerosisRecruitingNCT03217396
- The Swedish BioFINDER 2 StudyRecruitingNCT03174938Not applicable
- Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS PatientsRecruitingNCT03127267Phase 3
- Circulating Biomarker for Amyotrophic Lateral Sclerosis (ALS)RecruitingNCT03088839
- Diagnosing Frontotemporal Lobar DegenerationRecruitingNCT02964637
- Amyotrophic Lateral Sclerosis and the Innate Immune SystemRecruitingNCT02869048
- Neurologic Stem Cell Treatment StudyRecruitingNCT02795052Not applicable
- Imaging Biomarkers in ALSRecruitingNCT02567136
- Study to Investigate the Safety of the Transplantation (by Injection) of Human Glial Restricted Progenitor Cells (hGRPs; Q-Cells®) Into Subjects With Amyotrophic Lateral Sclerosis (ALS)Not yet recruitingNCT02478450Phase 1/2
- The National Amyotrophic Lateral Sclerosis RegistryRecruitingNCT01772602
- BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With TetraplegiaRecruitingNCT00912041Not applicable
- Derivation of Induced Pluripotent Stem Cells From an Existing Collection of Human Somatic CellsRecruitingNCT00801333
- The Pre-symptomatic Familial Amyotrophic Lateral Sclerosis (Pre-fALS) StudyRecruitingNCT00317616
- Clinical Research in ALS StudyRecruitingNCT00136500
- Study to Investigate the Long-term Safety of FAB122 in Patients With Amyotrophic Lateral SclerosisTerminatedNCT05866926Phase 3Results posted
- HEALEY ALS Platform Trial - Regimen G DNL343CompletedNCT05842941Phase 2/3Results posted
- HEALEY ALS Platform Trial - Regimen F ABBV-CLS-7262CompletedNCT05740813Phase 2/3Results posted
- Open-label Extension (OLE) Study of WVE-004 in Patients With C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) and/or Frontotemporal Dementia (FTD)TerminatedNCT05683860Phase 1/2Results posted
- Study of AMDX-2011P as a Retinal Tracer in Subjects With Neurodegenerative Diseases Associated With Amyloidogenic ProteinopathyCompletedNCT05542576Phase 1/2Results posted
- Treatment Combining Riluzole and IFB-088 in Bulbar Amyotrophic Lateral Sclerosis (TRIALS Protocol)CompletedNCT05508074Phase 2Results posted
- A Phase 3, Open-Label Extension of COURAGE-ALS (CY 5031)TerminatedNCT05442775Phase 3Results posted
- Study to Assess the Effects of PTC857 Treatment in Participants With Amyotrophic Lateral Sclerosis ALSTerminatedNCT05349721Phase 2Results posted
- Phase 2 Study for SAR443820 in Participants With Amyotrophic Lateral Sclerosis (ALS)TerminatedNCT05237284Phase 2Results posted
- Neurodegenerative Alzheimer's Disease and Amyotrophic Lateral Sclerosis (NADALS) Basket TrialCompletedNCT05189106Phase 1/2Results posted
- Study to Investigate the Efficacy and Safety of FAB122 (Daily Oral Edaravone) in Patients With Amyotrophic Lateral SclerosisCompletedNCT05178810Phase 3Results posted
- A 6-Month Extension Study to Assess the Long-Term Safety of Engensis in Amyotrophic Lateral SclerosisCompletedNCT05176093Phase 2Results posted
- Study of Safety, Tolerability, and Biological Activity of LAM-002A in C9ORF72-Associated Amyotrophic Lateral SclerosisCompletedNCT05163886Phase 2Results posted
- HEALEY ALS Platform Trial - Regimen E SLS-005 - TrehaloseCompletedNCT05136885Phase 2/3Results posted
- A Phase 2 Study to Evaluate AL001 in C9orf72-Associated ALSTerminatedNCT05053035Phase 2Results posted
- 3K3A-APC for Treatment of Amyotrophic Lateral Sclerosis (ALS)CompletedNCT05039268Phase 2Results posted